Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

TGF-β- and IL-2-containing anti-CD4-conjugated DiR-labeled nanoparticles

Based on

1 Articles
2015 Most recent source

Composition

1

TGF-β1 and IL-2 encapsulated avidin-coated PLGA nanoparticles

TGF-β1 and IL-2 encapsulated PLGA nanoparticles TGF-β- and IL-2-containing PLGA nanoparticles TGF-β-IL-2 nanoparticles
Type Nano Material
Formula
Role raw materials
2

biotin-anti-CD4 antibody

biotin-anti-CD4
Type Biomolecule
Formula
Role loaded material
3

1,1'-dioctadecyl-3,3,3',3'-tetra-methylindotricarbocyanine iodide

1,1'-dioctadecyl-3,3,3',3'-tetramethyl indotricarbocyanine iodide 1,1'-dioctadecyl-3,3,3',3'-tetramethylindo-tricarbocyanine iodide 1,1'-Dioctadecyl-3,3,3',3'-tetramethylindotricarbocyanine iodide 1,1'-dioctadecyl-3,3,3',3'-tetramethylindotricarbocyanine Iodide 1,1'-dioctadecyl-3,3,3',3'-tetramethylindotricarbocyanine iodide 1,1'-dioctadecyl-3,3,3-,3'-tetramethylindotricarbocyanine iodide 1,10-dioctadecyl-3,3,3',3'-tetramethylindotricarbocyanine iodide 1,1`-dioctadecyl-3,3,3`,3`-tetramethylindotricarbocyanine iodide 1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine iodide 10-dioctadecyl-3,3,3',3'-tetramethylindotricarbocyanine iodide 1,1-dioctadecyl-3,3,3,3-tetramethylindotricarbocyanine iodide 1,1'-dioctadecyl-3,3,3',3'- tetramethylindodicarbocyanine 1,1'-dioctadecyl-3,3,3',3'-tetramethylindo-dicarbocyanine 1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine 1,1'-dioctadecyltetramethyl indotricarbocyanine iodide 1,10-dioctadecyltetramethyl indotricarbocyanine iodide 1,1'-dioctadecyltetramethylindotricarbocyanine iodide DiIC18(7) DiOC18(7) DIR DiD DiR
Type Single Compound
Formula C63H101IN2
Role loaded material

Properties

Applications

Characterization

Biological effects

Biological system Test details Source

Full content is available to subscribers only

To view content please choose from the following:

Preparation

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial